Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Oral Contraceptives in Reproductive Age Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03919747
Recruitment Status : Recruiting
First Posted : April 18, 2019
Last Update Posted : April 18, 2019
Sponsor:
Information provided by (Responsible Party):
Mine Kiseli, Ufuk University

Brief Summary:
Contraception is an important issue in public health; especially when maternal risks and morbidities are considered. There is a need for consciousness about the contraceptive choices. The reproductive age women in Turkey may be stubborn or may choose to believe heath information. The oral contraceptive drugs are not used because of wrong beliefs. This survey study aims to investigate the consciousness and knowledge about the oral contraceptives in 3 different areas in Turkey.

Condition or disease
Contraception Behavior

Detailed Description:
In this study; surveys will be given to reproductive age women admitting to the obstetrics and gynecology departments in 3 different cities of Turkey. Survey questions start with the education and socioeconomical status of the participants. Mainly the questions include the knowledge, ever use about oral contraceptives.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 500 participants
Observational Model: Other
Time Perspective: Cross-Sectional
Official Title: The Awareness About Oral Contraceptives in Reproductive Age Women
Actual Study Start Date : January 2, 2019
Estimated Primary Completion Date : June 2, 2019
Estimated Study Completion Date : July 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Birth Control




Primary Outcome Measures :
  1. Knowledge about oral contraceptives [ Time Frame: 6 months of survey study ]
    The number of participants who had knowledge about the correct use of OC pills

  2. Contraindications of OC pills [ Time Frame: 6 months of survey study ]
    The number of participants who know the contraindications of OC pills /The number of participants who think that OC pills cause infertility


Secondary Outcome Measures :
  1. Knowledge difference in between different regions [ Time Frame: 6 months of survey study ]
    The number of participants who had knowledge about the correct use of OC pills in different regions

  2. Oral contraceptive use [ Time Frame: 6 months of survey study ]
    The number of participants that have ever used oral contraceptive pills



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Women are the investigation group
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Reproductive aged women
Criteria

Inclusion Criteria: The women admitting to the clinics -

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03919747


Contacts
Layout table for location contacts
Contact: Mine Kiseli, Assoc. Prof. +90-532-5080110 minekiseli@gmail.com
Contact: Asli Yarci Gursoy +90-532-6862822 asliyarci@gmail.com

Locations
Layout table for location information
Turkey
Karabuk University Hospital Recruiting
Karabük, Turkey
Contact: Sibel Mutlu         
Acıbadem Private Hospital Recruiting
Kayseri, Turkey
Contact: Elif Cinar         
Ufuk University Dr Ridvan Ege Hospital Recruiting
Ankara, Çankaya, Turkey, 06540
Contact: Mine Kiseli    5325080110    minekiseli@gmail.com   
Sponsors and Collaborators
Ufuk University
Investigators
Layout table for investigator information
Study Director: Recai Pabuccu, Prof. The Turkish Reproductive Medicine Association

Layout table for additonal information
Responsible Party: Mine Kiseli, Assoc. Prof., Ufuk University
ClinicalTrials.gov Identifier: NCT03919747     History of Changes
Other Study ID Numbers: 20180528/4
First Posted: April 18, 2019    Key Record Dates
Last Update Posted: April 18, 2019
Last Verified: April 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Mine Kiseli, Ufuk University:
oral contraceptives
knowledge

Additional relevant MeSH terms:
Layout table for MeSH terms
Contraceptive Agents
Contraceptives, Oral
Reproductive Control Agents
Physiological Effects of Drugs
Contraceptive Agents, Female